NCT05808387View on ClinicalTrials.gov

The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

June 5, 2025

Study Completion Date

June 5, 2026

Conditions
Coronary Artery DiseaseMenopauseEndothelial Dysfunction
Interventions
DIETARY_SUPPLEMENT

Resveratrol

Trans-resveratrol, 1000 mg daily for 90 days

DIETARY_SUPPLEMENT

Placebo

Starch, 1000 mg daily for 90 days

Trial Locations (1)

05403900

RECRUITING

INCOR- Heart Institute, São Paulo

All Listed Sponsors
lead

InCor Heart Institute

OTHER